Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Leverkus

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 11, 2004
[Photoprotection: effects and side effects]M Leverkus
Experimental Cell Research|May 1, 1997
Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytesM Leverkus, M Yaar, B A Gilchrest
Cell Death & Disease|September 12, 2014
The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skinP Geserick, J Wang, M Feoktistova, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 21, 2008
[Livid polycyclic plaques of the lower extremities]V Bekou, I Franke, H Gollnick, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 7, 1999
[Intertriginous acantholytic dyskeratosis: abortive form of Darier disease or a specific entity?]M Leverkus, C Rose, E B Bröcker, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 1, 2012
Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their managementI Manousaridis, S Mavridou, S Goerdt, et al.
The British Journal of Dermatology|September 25, 2009
UV-induced squamous cell carcinoma--a role for antiapoptotic signalling pathwaysP M Rodust, E Stockfleth, C Ulrich, et al.
Dermatology (Basel, Switzerland)|July 9, 2008
Metastatic squamous cell carcinoma of the ankle in long-standing untreated acrodermatitis chronica atrophicansM Leverkus, A M Finner, A Pokrywka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2016
Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literatureG Balakirski, A Alkhateeb, H F Merk, et al.
Journal of Wound Care|April 3, 1999
Effect of chronic wound fluid on fibroblastsT J Phillips, H O Al-Amoudi, M Leverkus, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|February 11, 2004
[Photoprotection: effects and side effects]M Leverkus
Experimental Cell Research|May 1, 1997
Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytesM Leverkus, M Yaar, B A Gilchrest
Cell Death & Disease|September 12, 2014
The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skinP Geserick, J Wang, M Feoktistova, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 21, 2008
[Livid polycyclic plaques of the lower extremities]V Bekou, I Franke, H Gollnick, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 7, 1999
[Intertriginous acantholytic dyskeratosis: abortive form of Darier disease or a specific entity?]M Leverkus, C Rose, E B Bröcker, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 1, 2012
Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their managementI Manousaridis, S Mavridou, S Goerdt, et al.
The British Journal of Dermatology|September 25, 2009
UV-induced squamous cell carcinoma--a role for antiapoptotic signalling pathwaysP M Rodust, E Stockfleth, C Ulrich, et al.
Dermatology (Basel, Switzerland)|July 9, 2008
Metastatic squamous cell carcinoma of the ankle in long-standing untreated acrodermatitis chronica atrophicansM Leverkus, A M Finner, A Pokrywka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2016
Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literatureG Balakirski, A Alkhateeb, H F Merk, et al.
Journal of Wound Care|April 3, 1999
Effect of chronic wound fluid on fibroblastsT J Phillips, H O Al-Amoudi, M Leverkus, et al.
Pageof 4